
Nurix Therapeutics Inc
NASDAQ:NRIX

Intrinsic Value
The intrinsic value of one
NRIX
stock under the Base Case scenario is
9.88
USD.
Compared to the current market price of 11.98 USD,
Nurix Therapeutics Inc
is
Overvalued by 18%.
The Intrinsic Value is calculated as the average of DCF and Relative values:

Valuation History
Nurix Therapeutics Inc
Fundamental Analysis


Revenue & Expenses Breakdown
Nurix Therapeutics Inc
Balance Sheet Decomposition
Nurix Therapeutics Inc
Current Assets | 563.7m |
Cash & Short-Term Investments | 549.7m |
Other Current Assets | 14m |
Non-Current Assets | 51.3m |
PP&E | 44.8m |
Other Non-Current Assets | 6.5m |
Free Cash Flow Analysis
Nurix Therapeutics Inc
USD | |
Free Cash Flow | USD |
Earnings Waterfall
Nurix Therapeutics Inc
Revenue
|
56.4m
USD
|
Operating Expenses
|
-287.1m
USD
|
Operating Income
|
-230.7m
USD
|
Other Expenses
|
22.3m
USD
|
Net Income
|
-208.4m
USD
|
NRIX Profitability Score
Profitability Due Diligence
Nurix Therapeutics Inc's profitability score is 17/100. The higher the profitability score, the more profitable the company is.

Score
Nurix Therapeutics Inc's profitability score is 17/100. The higher the profitability score, the more profitable the company is.
NRIX Solvency Score
Solvency Due Diligence
Nurix Therapeutics Inc's solvency score is 69/100. The higher the solvency score, the more solvent the company is.

Score
Nurix Therapeutics Inc's solvency score is 69/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
NRIX Price Targets Summary
Nurix Therapeutics Inc
According to Wall Street analysts, the average 1-year price target for
NRIX
is 30.9 USD
with a low forecast of 16.16 USD and a high forecast of 43.05 USD.
Dividends
Current shareholder yield for NRIX is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
NRIX
stock under the Base Case scenario is
9.88
USD.
Compared to the current market price of 11.98 USD,
Nurix Therapeutics Inc
is
Overvalued by 18%.